Uniplan Investment Counsel’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Uniplan Investment Counsel’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,541,531	Closed	-$4.61M	–	137
2022 Q1	$4.61M	Buy	1,541,531 +10,947	+0.7%	+$24.1K	0.27%	73
2021 Q4	$1.96M	Buy	1,530,584 +984,110	+180%	+$1.97M	0.11%	124
2021 Q3	$1.24M	Sell	546,474 -2,599	-0.5%	-$9.34K	0.08%	132
2021 Q2	$3.12M	Buy	549,073 +199,370	+57%	+$1.33M	0.18%	103
2021 Q1	$2.2M	Buy	+349,703	New	+$2.62M	0.14%	115

Uniplan Investment Counsel's TLMD Position: Q2 2022 in Review

Uniplan Investment Counsel sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 1,541,531 shares — an estimated $4.61M sold.

Uniplan Investment Counsel first reported a position in TLMD in Q1 2021 and held it in 5 quarters. The position peaked at $4.61M in Q1 2022. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

Uniplan Investment Counsel reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Uniplan Investment Counsel sold 1,541,531 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $4.61M.
Uniplan Investment Counsel first reported a position in SOC Telemed, Inc. Class A Common Stock in Q1 2021 and held it in 5 quarters.
Uniplan Investment Counsel's SOC Telemed, Inc. Class A Common Stock position peaked at $4.61M in Q1 2022.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on Uniplan Investment Counsel's 13F filing for Q2 2022, filed 15 Aug 2022.